Villegas I - Search Results

1

Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.

de la Lastra CA, Villegas I. de la Lastra CA, et al. Among authors: villegas i. Mol Nutr Food Res. 2005 May;49(5):405-30. doi: 10.1002/mnfr.200500022. Mol Nutr Food Res. 2005. PMID: 15832402 Review.

2

Anti-oxidant mechanisms involved in gastroprotective effects of quercetin.

Martín MJ, La-Casa C, Alarcón-de-la-Lastra C, Cabeza J, Villegas I, Motilva V. Martín MJ, et al. Among authors: villegas i. Z Naturforsch C J Biosci. 1998 Jan-Feb;53(1-2):82-8. doi: 10.1515/znc-1998-1-215. Z Naturforsch C J Biosci. 1998. PMID: 9528125

3

Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.

Villegas I, Alarcón de la Lastra C, La Casa C, Motilva V, Martín MJ. Villegas I, et al. Eur J Pharmacol. 2001 Feb 23;414(1):79-86. doi: 10.1016/s0014-2999(00)00883-9. Eur J Pharmacol. 2001. PMID: 11230998

4

Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.

Villegas I, Martín MJ, La Casa C, Motilva V, De La Lastra CA. Villegas I, et al. Free Radic Res. 2002 Jul;36(7):769-77. doi: 10.1080/10715760290032575. Free Radic Res. 2002. PMID: 12180128

5

Gastric damage induced by subchronic administration of preferential cyclooxygenase-1 and cyclooxygenase-2 inhibitors in rats.

Villegas I, Alarcón de la Lastra C, Martín MJ, Motilva V, La Casa García C. Villegas I, et al. Pharmacology. 2002 Oct;66(2):68-75. doi: 10.1159/000065628. Pharmacology. 2002. PMID: 12207113

6

Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats.

Villegas I, La Casa C, Orjales A, Alarcón de la Lastra C. Villegas I, et al. Eur J Pharmacol. 2003 Jan 24;460(2-3):209-18. doi: 10.1016/s0014-2999(02)02949-7. Eur J Pharmacol. 2003. PMID: 12559383

7

A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.

Villegas I, Alarcón de la Lastra C, Orjales A, La Casa C. Villegas I, et al. Int Immunopharmacol. 2003 Dec;3(13-14):1731-41. doi: 10.1016/j.intimp.2003.07.002. Int Immunopharmacol. 2003. PMID: 14636824

8

The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats.

Martín AR, Villegas I, La Casa C, Alarcón de la Lastra C. Martín AR, et al. Among authors: villegas i. Eur J Pharmacol. 2003 Nov 28;481(2-3):281-91. doi: 10.1016/j.ejphar.2003.09.033. Eur J Pharmacol. 2003. PMID: 14642796

9

Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.

Villegas I, La Casa C, de la Lastra CA, Motilva V, Herrerías JM, Martín MJ. Villegas I, et al. Life Sci. 2004 Jan 2;74(7):873-84. doi: 10.1016/j.lfs.2003.07.021. Life Sci. 2004. PMID: 14659976

10

Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats.

Martín AR, Villegas I, La Casa C, de la Lastra CA. Martín AR, et al. Among authors: villegas i. Biochem Pharmacol. 2004 Apr 1;67(7):1399-410. doi: 10.1016/j.bcp.2003.12.024. Biochem Pharmacol. 2004. PMID: 15013856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results